TABLE 2.
| RT002: 2009–2017 (n = 348) | RT002: 2017–2021 (n = 263) | |
|---|---|---|
| Age | 72.14 (57.93–81.56) | 72.77 (59.11–82.15) |
| Men | 155/348 (44.54) | 143/263 (54.37) P = 0.015b |
| Severe CDI | 88/325 (27.08) | 40/259 (15.44) P < 0.001b |
| Complicated course | 48/290 (16.55) | 28/250 (11.20) |
| CDI mortality | 13/290 (4.48) | 5/250 (2.00) |
Data are shown as no. of cases (%) or, for age, as median (Q1–Q3) due to skewed distribution.
P < 0.05 after correction for antibiotic use.
P < 0.05 after correction for age and antibiotic use. An adjusted alpha level (α = 0.005) was used for severe CDI and CDI-related mortality. The supplementary material includes a detailed table of clinical characteristics and a combined heatmap visualizing the pattern of these characteristics across the RT groups.